Cargando…
Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis
BACKGROUND: Use of patient-reported outcomes (PROs) and patient and public engagement are critical ingredients of pragmatic trials, which are intended to be patient centered. Engagement of patients and members of the public in selecting the primary trial outcome and determining the target difference...
Autores principales: | Vanderhout, Shelley, Fergusson, Dean A., Cook, Jonathan A., Taljaard, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824332/ https://www.ncbi.nlm.nih.gov/pubmed/35134080 http://dx.doi.org/10.1371/journal.pmed.1003896 |
Ejemplares similares
-
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
por: Ross, Joseph S, et al.
Publicado: (2012) -
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
por: Ross, Joseph S., et al.
Publicado: (2009) -
Obstacles to the reuse of study metadata in ClinicalTrials.gov
por: Miron, Laura, et al.
Publicado: (2020) -
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis
por: Jones, Christopher W, et al.
Publicado: (2020) -
Registration of phase 3 crossover trials on ClinicalTrials.gov
por: Zeng, Lijuan, et al.
Publicado: (2020)